Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

Summary: Many vaccines, including those using recombinant antigen subunits, rely on adjuvant(s) to enhance the efficacy of the host immune responses. Among the few adjuvants clinically approved, QS-21, a saponin-based immunomodulatory molecule isolated from the tree bark of Quillaja saponaria (QS) i...

Full description

Bibliographic Details
Main Authors: Xiangmin Lv, Jesse Martin, Heather Hoover, Bishnu Joshi, Margaret Wilkens, David A. Ullisch, Thomas Leibold, John S. Juchum, Sanket Revadkar, Barbara Kalinovska, Justin Keith, Adam Truby, Gui Liu, Elaine Sun, John Haserick, Jon DeGnore, Joseph Conolly, Adrian V.S. Hill, John Baldoni, Charlotte Kensil, Dan Levey, Alexandra J. Spencer, Gilbert Gorr, Mark Findeis, Antoine Tanne
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S258900422400227X
_version_ 1797317448182005760
author Xiangmin Lv
Jesse Martin
Heather Hoover
Bishnu Joshi
Margaret Wilkens
David A. Ullisch
Thomas Leibold
John S. Juchum
Sanket Revadkar
Barbara Kalinovska
Justin Keith
Adam Truby
Gui Liu
Elaine Sun
John Haserick
Jon DeGnore
Joseph Conolly
Adrian V.S. Hill
John Baldoni
Charlotte Kensil
Dan Levey
Alexandra J. Spencer
Gilbert Gorr
Mark Findeis
Antoine Tanne
author_facet Xiangmin Lv
Jesse Martin
Heather Hoover
Bishnu Joshi
Margaret Wilkens
David A. Ullisch
Thomas Leibold
John S. Juchum
Sanket Revadkar
Barbara Kalinovska
Justin Keith
Adam Truby
Gui Liu
Elaine Sun
John Haserick
Jon DeGnore
Joseph Conolly
Adrian V.S. Hill
John Baldoni
Charlotte Kensil
Dan Levey
Alexandra J. Spencer
Gilbert Gorr
Mark Findeis
Antoine Tanne
author_sort Xiangmin Lv
collection DOAJ
description Summary: Many vaccines, including those using recombinant antigen subunits, rely on adjuvant(s) to enhance the efficacy of the host immune responses. Among the few adjuvants clinically approved, QS-21, a saponin-based immunomodulatory molecule isolated from the tree bark of Quillaja saponaria (QS) is used in complex formulations in approved effective vaccines. High demand of the QS raw material as well as manufacturing scalability limitation has been barriers here. We report for the first-time successful plant cell culture production of QS-21 having structural, chemical, and biologic, properties similar to the bark extracted product. These data ensure QS-21 and related saponins are broadly available and accessible to drug developers.
first_indexed 2024-03-08T03:35:05Z
format Article
id doaj.art-4ce190e0d41a4a90adc8bb0b7532bfc5
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-03-08T03:35:05Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-4ce190e0d41a4a90adc8bb0b7532bfc52024-02-10T04:45:10ZengElsevieriScience2589-00422024-03-01273109006Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell cultureXiangmin Lv0Jesse Martin1Heather Hoover2Bishnu Joshi3Margaret Wilkens4David A. Ullisch5Thomas Leibold6John S. Juchum7Sanket Revadkar8Barbara Kalinovska9Justin Keith10Adam Truby11Gui Liu12Elaine Sun13John Haserick14Jon DeGnore15Joseph Conolly16Adrian V.S. Hill17John Baldoni18Charlotte Kensil19Dan Levey20Alexandra J. Spencer21Gilbert Gorr22Mark Findeis23Antoine Tanne24Agenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAPhyton Biotech GmbH, Ahrensburg, GermanyPhyton Biotech GmbH, Ahrensburg, GermanyPhyton Biotech LLC, 1503 Cliveden Avenue, Delta, BC V3M 6P7, CanadaAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UKSaponiQx, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAAgenus, Inc, Lexington MA, USAThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UKSaponiQx, Lexington MA, USASaponiQx, Lexington MA, USAAgenus, Inc, Lexington MA, USAThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, College of Health, Medicine & Wellbeing; Immune Health Program, New Lambton Heights, NSW, AustraliaPhyton Biotech GmbH, Ahrensburg, GermanyAgenus, Inc, Lexington MA, USASaponiQx, Lexington MA, USA; Corresponding authorSummary: Many vaccines, including those using recombinant antigen subunits, rely on adjuvant(s) to enhance the efficacy of the host immune responses. Among the few adjuvants clinically approved, QS-21, a saponin-based immunomodulatory molecule isolated from the tree bark of Quillaja saponaria (QS) is used in complex formulations in approved effective vaccines. High demand of the QS raw material as well as manufacturing scalability limitation has been barriers here. We report for the first-time successful plant cell culture production of QS-21 having structural, chemical, and biologic, properties similar to the bark extracted product. These data ensure QS-21 and related saponins are broadly available and accessible to drug developers.http://www.sciencedirect.com/science/article/pii/S258900422400227Xnatural product synthesismedical biochemistrycellPhytochemistryBioactive plant product
spellingShingle Xiangmin Lv
Jesse Martin
Heather Hoover
Bishnu Joshi
Margaret Wilkens
David A. Ullisch
Thomas Leibold
John S. Juchum
Sanket Revadkar
Barbara Kalinovska
Justin Keith
Adam Truby
Gui Liu
Elaine Sun
John Haserick
Jon DeGnore
Joseph Conolly
Adrian V.S. Hill
John Baldoni
Charlotte Kensil
Dan Levey
Alexandra J. Spencer
Gilbert Gorr
Mark Findeis
Antoine Tanne
Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
iScience
natural product synthesis
medical biochemistry
cell
Phytochemistry
Bioactive plant product
title Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
title_full Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
title_fullStr Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
title_full_unstemmed Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
title_short Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture
title_sort chemical and biological characterization of vaccine adjuvant qs 21 produced via plant cell culture
topic natural product synthesis
medical biochemistry
cell
Phytochemistry
Bioactive plant product
url http://www.sciencedirect.com/science/article/pii/S258900422400227X
work_keys_str_mv AT xiangminlv chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT jessemartin chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT heatherhoover chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT bishnujoshi chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT margaretwilkens chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT davidaullisch chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT thomasleibold chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT johnsjuchum chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT sanketrevadkar chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT barbarakalinovska chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT justinkeith chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT adamtruby chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT guiliu chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT elainesun chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT johnhaserick chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT jondegnore chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT josephconolly chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT adrianvshill chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT johnbaldoni chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT charlottekensil chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT danlevey chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT alexandrajspencer chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT gilbertgorr chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT markfindeis chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture
AT antoinetanne chemicalandbiologicalcharacterizationofvaccineadjuvantqs21producedviaplantcellculture